Esther Oliva Selected Research

Endometrial Stromal Tumors

3/2009	Calretinin: diagnostic utility in the female genital tract.
7/2008	Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
10/2007	CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
4/2002	An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esther Oliva Research Topics

Disease

94	Neoplasms (Cancer) 05/2022 - 01/2002
34	Carcinoma (Carcinomatosis) 05/2022 - 02/2002
18	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2005
14	Adenocarcinoma 01/2022 - 02/2002
10	Leiomyosarcoma 01/2022 - 04/2002
9	Endometrioid Carcinoma 01/2019 - 01/2005
8	Endometrial Stromal Sarcoma 01/2022 - 01/2002
8	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 05/2006
7	Neoplasm Metastasis (Metastasis) 11/2019 - 01/2005
7	Ovarian Neoplasms (Ovarian Cancer) 12/2014 - 01/2003
6	Renal Cell Carcinoma (Grawitz Tumor) 09/2019 - 01/2005
4	Perivascular Epithelioid Cell Neoplasms 01/2022 - 03/2011
4	Carcinosarcoma 01/2021 - 01/2011
4	Metaplasia 01/2019 - 01/2002
4	Leiomyoma (Uterine Fibroids) 11/2017 - 04/2002
4	Endometrial Stromal Tumors 03/2009 - 04/2002
3	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2008
3	Smooth Muscle Tumor 11/2020 - 04/2002
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019 - 01/2005
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2019 - 01/2016
3	Carcinogenesis 01/2018 - 01/2005
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2017 - 02/2012
3	Microsatellite Instability 03/2017 - 10/2005
3	Necrosis 10/2014 - 03/2010
3	Wilms Tumor (Wilm's Tumor) 01/2011 - 11/2003
3	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 10/2010 - 01/2005
2	Mesothelioma 05/2022 - 03/2009
2	Pain (Aches) 05/2021 - 03/2015
2	Cysts 05/2021 - 10/2010
2	Hyperplasia 01/2021 - 10/2015
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 10/2018 - 03/2011
2	Granulosa Cell Tumor 01/2018 - 10/2007
2	Small Cell Carcinoma 02/2016 - 01/2003
2	Testicular Neoplasms (Testicular Cancer) 09/2015 - 02/2013
2	Tuberous Sclerosis (Bourneville's Disease) 07/2014 - 03/2011
2	Angiomyolipoma 10/2013 - 03/2011

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
13	DesminIBA 01/2022 - 01/2002
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2010
10	Cyclin D1IBA 01/2022 - 05/2012
9	Inhibins (Inhibin)IBA 01/2021 - 04/2002
9	Calbindin 2IBA 01/2021 - 01/2005
9	Keratins (Keratin)IBA 06/2017 - 02/2002
8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
7	Estrogen ReceptorsIBA 01/2022 - 01/2009
7	MART-1 AntigenIBA 01/2022 - 12/2010
7	ParaffinIBA 01/2021 - 01/2003
7	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2011
7	VimentinIBA 01/2019 - 01/2002
7	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2018 - 04/2002
7	AntibodiesIBA 05/2014 - 04/2002
6	Hormones (Hormone)IBA 01/2022 - 07/2008
6	beta CateninIBA 01/2021 - 01/2005
6	MucinsIBA 01/2021 - 01/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2010
4	alpha-methylacyl-CoA racemaseIBA 01/2022 - 06/2004
4	CAM 5.2 antigenIBA 01/2021 - 02/2005
4	Biological ProductsIBA 01/2019 - 07/2007
4	Cadherins (E-Cadherin)IBA 01/2019 - 10/2010
4	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 02/2005
4	Messenger RNA (mRNA)IBA 01/2018 - 09/2003
4	CateninsIBA 10/2015 - 10/2010
3	trans-sodium crocetinate (crocetin)IBA 01/2022 - 07/2014
3	Keratin-7 (Cytokeratin 7)IBA 01/2021 - 11/2003
3	Anaplastic Lymphoma KinaseIBA 12/2020 - 01/2009
3	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2018
3	ChromograninsIBA 06/2017 - 02/2005
3	SteroidsIBA 07/2015 - 10/2007
3	ErbB Receptors (EGF Receptor)IBA 05/2013 - 10/2005
3	Hematoxylin (Haematoxylon)IBA 05/2013 - 06/2004
3	Eosine Yellowish-(YS) (Eosin)IBA 05/2013 - 06/2004
3	Estrogens (Estrogen)FDA Link 05/2012 - 01/2005
3	Coloring Agents (Dyes)IBA 05/2011 - 06/2004
3	Hepatocyte Nuclear FactorsIBA 03/2011 - 01/2009
3	ThrombomodulinIBA 01/2005 - 01/2003
3	Uroplakin IIIIBA 01/2005 - 01/2003
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2004 - 06/2002
2	Claudin-4IBA 05/2022 - 08/2020
2	Trefoil Factor-2IBA 01/2022 - 01/2021
2	Cathepsin KIBA 01/2022 - 10/2018
2	Hepatocyte Nuclear Factor 1-betaIBA 01/2019 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2018 - 01/2004
2	IronIBA 02/2018 - 10/2016
2	Protein Isoforms (Isoforms)IBA 01/2018 - 11/2010
2	Phosphotransferases (Kinase)IBA 01/2018 - 06/2011
2	Pharmaceutical PreparationsIBA 10/2017 - 03/2014
2	Lenalidomide (CC 5013)FDA Link 10/2017 - 03/2015
2	CyclinsIBA 05/2014 - 10/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2013 - 05/2006
2	MicroRNAs (MicroRNA)IBA 02/2013 - 01/2011

Therapy/Procedure

16	Therapeutics 01/2022 - 11/2002
10	Hysterectomy 05/2021 - 01/2002
5	Radiotherapy 11/2021 - 02/2012
5	Drug Therapy (Chemotherapy) 11/2021 - 06/2002
3	Curettage 05/2021 - 01/2002
2	Orchiectomy (Orchidectomy) 01/2022 - 09/2015
2	Neoadjuvant Therapy 01/2021 - 12/2014
2	Immunotherapy 11/2019 - 10/2005
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 07/2008
2	Cystectomy 02/2014 - 05/2013